• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    2/1/23 1:43:03 PM ET
    $BGXX
    $BIDU
    $BSFC
    $CEMI
    Medicinal Chemicals and Botanical Products
    Health Care
    Computer Software: Programming Data Processing
    Technology
    Get the next $BGXX alert in real time by email

    Gainers

    • Versus Systems Inc. (NASDAQ:VS) surged 270% to $2.26 after the company announced it will partner with Resolve to bring generative AI and gamification to customer payments and credit management.
    • EBET, Inc. (NASDAQ:EBET) gained 108% to $1.97
    • Motorsport Games Inc. (NASDAQ:MSGM) shares jumped 92.3% to $41.15. Motorsport Games agreed to raise $3.9 million at par via private placement of shares for developing multiple games, working capital and general corporate purposes.
    • Bright Green Corporation (NASDAQ:BGXX) gained 91.3% to $0.9993. Bright Green announced plans to raise $500 million under EB-5 Capital Program.
    • Recruiter.com Group, Inc. (NASDAQ:RCRT) rose 80.4% to $0.8520. Recruiter.com Group reported the launch of a comprehensive content series that explores the powerful impact of the artificial intelligence technology, ChatGPT, on talent acquisition and recruiting.
    • SharpLink Gaming Ltd. (NASDAQ:SBET) gained 50% to $0.81
    • Iveda Solutions, Inc. (NASDAQ:IVDA) jumped 47.2% to $1.39
    • Mobile Global Esports Inc. (NASDAQ:MGAM) gained 36.1% to $3.51 after jumping 158% on Tuesday. Mobile Global Esports said Nicholas (Nick) Venezia has joined MOGO as Chief Data Officer.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares climbed 36% to $2.27 after gaining around 10% on Tuesday.
    • Impac Mortgage Holdings, Inc. (NYSE:IMH) jumped 25% to $0.3350.
    • Chembio Diagnostics, Inc. (NASDAQ:CEMI) rose 23.3% to $0.4401. Biosynex and Chembio Diagnostics reported a definitive acquisition agreement.
    • Rapid7, Inc. (NASDAQ:RPD) gained 23.2% to $49.13. Rapid7 is working with Goldman Sachs Group to explore a potential sale, Reuters reported.
    • ERYTECH Pharma S.A. (NASDAQ:ERYP) jumped 22.2% to $1.10.
    • Engine Gaming and Media, Inc. (NASDAQ:GAME) gained 22.2% to $1.4673.
    • Pintec Technology Holdings Limited (NASDAQ:PT) jumped 22.2% to $0.4690.
    • Peloton Interactive, Inc. (NASDAQ:PTON) gained 21% to $15.58 after the company reported better-than-expected Q2 sales results and issued guidance.
    • MicroVision, Inc. (NASDAQ:MVIS) gained 16.3% to $2.9187.
    • Mercury Systems, Inc. (NASDAQ:MRCY) jumped 16.2% to $58.08 following Q2 results.
    • Edible Garden AG Incorporated (NASDAQ:EDBL) shares gained 14.9% to $12.40.
    • LivePerson, Inc. (NASDAQ:LPSN) gained 14.3% to $14.72. LivePerson highlighted Conversational Cloud with Generative AI.
    • TransCode Therapeutics, Inc. (NASDAQ:RNAZ) rose 14.3% to $0.8578 after the company reported preclinical results with immunotherapy candidate TTX-RIGA in melanoma.
    • Baidu, Inc. (NASDAQ:BIDU) gained 13.3% to $152.55.
    • Lionheart III Corp (NASDAQ:LION) rose 12.2% to $11.68 after dropping over 10% on Tuesday.
    • TMC The Metals Company Inc. (NASDAQ:TMC) rose 12.2% to $0.9804. TMC The Metals Company recently filed prospectus for offering of up to $30 million common shares.
    • Marin Software Incorporated (NASDAQ:MRIN) rose 9.1% to $1.32 after the company disclosed a new integration with Yahoo to enable enhanced campaign buying and optimization for advertisers.

    Losers

    • Taysha Gene Therapies, Inc. (NASDAQ:TSHA) fell 34.2% to $1.0799 after the company issued an update on TSHA-120 program in giant axonal neuropathy and a 2023 corporate outlook.
    • Cyren Ltd. (NASDAQ:CYRN) dropped 28% to $0.5366. Cyren announced global reduction in force by 121 employees representing substantially all of the company's workforce.
    • Evelo Biosciences, Inc. (NASDAQ:EVLO) dropped 22.8% to $0.8024. Evelo Biosciences said data from first three cohorts of EDP1815 Phase 2 trial in atopic dermatitis did not meet primary endpoint.
    • SOBR Safe, Inc. (NASDAQ:SOBR) fell 16.1% to $1.51. SOBR Safe shares jumped 62% on Tuesday after the company announced that its first two SOBRcheck installations in the oil and gas industry were successful, driving expansion across all US locations for TerraTech Services.
    • Varex Imaging Corporation (NASDAQ:VREX) dropped 15% to $18.25 after the company issued Q2 EPS guidance below analyst estimates.
    • Blue Star Foods Corp. (NASDAQ:BSFC) fell 14.4% to $0.4450 after gaining more than 24% on Tuesday. Blue Star Foods entered into supply agreement with Just Food For Dogs for up to $4 million annually.
    • Hawaiian Holdings, Inc. (NASDAQ:HA) dropped 14.2% to $10.57 following downbeat Q4 sales.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) fell 13.9% to $4.2950 after declining around 8% on Tuesday. G Medical Innovations recently announced it received notice of patent issuance from the United States Patent and Trademark Office (USPTO) for vital signs sensors.
    • WestRock Company (NYSE:WRK) shares fell 13% to $34.15 after the company reported worse-than-expected Q1 adjusted EPS and sales results. The company also removed FY23 outlook in light of uncertain macroeconomic conditions.
    • Snap Inc. (NYSE:SNAP) shares fell 12.6% to $10.08 after the company posted a net loss for the fourth quarter and said revenue could drop by as much as 10% for the current quarter.
    • Hillstream BioPharma, Inc. (NASDAQ:HILS) shares fell 12.5% to $1.05. Hillstream BioPharma shares jumped over 78% on Tuesday after the company announced signing an exclusive option agreement with Dana-Farber Cancer Institute to license technology targeting the MUC1-C oncoprotein..
    • Electronic Arts Inc. (NASDAQ:EA) shares fell 12% to $113.29 after the company posted Q3 results and issued weak forecast.
    • Janux Therapeutics, Inc. (NASDAQ:JANX) dipped 10.6% to $19.86.
    • Nuvve Holding Corp. (NASDAQ:NVVE) dropped 8.8% to $1.25. Nuvve filed for a common stock offering of up to $25 million.
    • Cue Health Inc. (NASDAQ:HLTH) fell 8.2% to $2.4050
    • Match Group, Inc. (NASDAQ:MTCH) fell 7.7% to $49.98 after the company reported worse-than-expected financial results for its fourth quarter and issued weak guidance.
    • Western Digital Corporation (NASDAQ:WDC) dropped 3.3% to $42.50 after the company reported mixed fiscal second-quarter results and issued weak guidance.

    Now Read This: $1M Bet On Golden Entertainment? Check Out These 3 Stocks Insiders Are Buying

    Get the next $BGXX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BGXX
    $BIDU
    $BSFC
    $CEMI

    CompanyDatePrice TargetRatingAnalyst
    Rapid7 Inc.
    $RPD
    2/11/2026$9.00Buy → Neutral
    UBS
    Rapid7 Inc.
    $RPD
    2/11/2026$10.00Buy → Hold
    Canaccord Genuity
    Snap Inc.
    $SNAP
    2/10/2026$7.30Neutral → Buy
    Arete
    Peloton Interactive Inc.
    $PTON
    2/10/2026Buy → Hold
    Argus
    Snap Inc.
    $SNAP
    2/6/2026$5.50Sell → Hold
    Stifel
    Peloton Interactive Inc.
    $PTON
    2/6/2026$8.00 → $6.00Market Perform
    Telsey Advisory Group
    Snap Inc.
    $SNAP
    2/5/2026$10.00Neutral → Buy
    BofA Securities
    Western Digital Corporation
    $WDC
    1/30/2026$200.00 → $325.00Buy
    TD Cowen
    More analyst ratings

    $BGXX
    $BIDU
    $BSFC
    $CEMI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Tan Irving

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    3/24/26 6:17:37 PM ET
    $WDC
    Electronic Components
    Technology

    SEC Form 4 filed by Davis Brian Scott

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    3/24/26 5:53:05 PM ET
    $WDC
    Electronic Components
    Technology

    SEC Form 4 filed by Shesky Craig

    4 - TMC the metals Co Inc. (0001798562) (Issuer)

    3/24/26 5:41:09 PM ET
    $TMC
    Metal Mining
    Basic Materials

    $BGXX
    $BIDU
    $BSFC
    $CEMI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

    For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

    11/9/23 2:30:20 PM ET
    $SRAX
    $SNAP
    Advertising
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $BGXX
    $BIDU
    $BSFC
    $CEMI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Kras James E. bought $2,050 worth of shares (3,700 units at $0.55), increasing direct ownership by 102% to 7,317 units (SEC Form 4)

    4 - Edible Garden AG Inc (0001809750) (Issuer)

    1/5/26 8:51:35 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Director Delta John bought $13,020 worth of shares (5,000 units at $2.60), increasing direct ownership by 71% to 12,000 units (SEC Form 4)

    4 - Motorsport Games Inc. (0001821175) (Issuer)

    12/12/25 5:31:22 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    Director Jana Partners Management, Lp bought $652,672 worth of shares (41,545 units at $15.71) (SEC Form 4)

    4 - Rapid7, Inc. (0001560327) (Issuer)

    12/4/25 7:00:20 PM ET
    $RPD
    Computer Software: Prepackaged Software
    Technology

    $BGXX
    $BIDU
    $BSFC
    $CEMI
    SEC Filings

    View All

    SEC Form 144 filed by TMC the metals company Inc.

    144 - TMC the metals Co Inc. (0001798562) (Subject)

    3/24/26 5:16:57 PM ET
    $TMC
    Metal Mining
    Basic Materials

    SEC Form 25-NSE filed by Nuvve Holding Corp.

    25-NSE - Nuvve Holding Corp. (0001836875) (Subject)

    3/24/26 8:24:35 AM ET
    $NVVE
    Electrical Products
    Industrials

    SEC Form 144 filed by Varex Imaging Corporation

    144 - Varex Imaging Corp (0001681622) (Subject)

    3/20/26 9:52:07 AM ET
    $VREX
    Industrial Machinery/Components
    Technology

    $BGXX
    $BIDU
    $BSFC
    $CEMI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rapid7 downgraded by UBS with a new price target

    UBS downgraded Rapid7 from Buy to Neutral and set a new price target of $9.00

    2/11/26 8:18:36 AM ET
    $RPD
    Computer Software: Prepackaged Software
    Technology

    Rapid7 downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Rapid7 from Buy to Hold and set a new price target of $10.00

    2/11/26 7:50:43 AM ET
    $RPD
    Computer Software: Prepackaged Software
    Technology

    Snap upgraded by Arete with a new price target

    Arete upgraded Snap from Neutral to Buy and set a new price target of $7.30

    2/10/26 7:58:39 AM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    $BGXX
    $BIDU
    $BSFC
    $CEMI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Edible Garden Partners with Steadfast City Economic & Community Partners to Drive Evolution Toward Farm-to-Formula® Ready-to-Drink Midwest Tetra Pak Platform

    BELVIDERE, NJ , March 25, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, and clean-label food innovation, today announced it has engaged Steadfast City Economic & Community Partners, a nationally recognized development and planning firm, to support the optimization and execution of its Midwest platform initiative in collaboration with Tetra Pak. The engagement is designed to support site planning, development strategy, and long-term scalability for a facility that is expected to play a significant role in Edibl

    3/25/26 9:10:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome

    FDA indicated that a single Phase 3 study may be sufficient to support marketing approval in the U.S. FDA expressed openness to an alternative study design for Phase 3 that would likely not include a traditional upfront vehicle or placebo control Quoin remains on track to initiate a Phase 3 study and complete Phase 3 patient recruitment in 2026 and potentially file for NDA approval in 2027 ASHBURN, Va., March 25, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) ("Quoin" or the "Company"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today provided a clinical and regulatory update from its recent constructive Type C meeting

    3/25/26 8:30:00 AM ET
    $QNRX
    Medical/Dental Instruments
    Health Care

    Edible Garden Schedules Fourth Quarter and Full Year Ended December 31, 2025, Financial Results and Business Update Conference Call

    BELVIDERE, NJ, March 24, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leader in controlled environment agriculture (CEA), locally grown, organic, better-for-you, sustainable produce and products, announced today that it will host a conference call on Tuesday March 31, 2026, at 4:30 PM Eastern Time to discuss financial results for the quarter and year ended December 31, 2025, and provide a business update. The conference call will be available via telephone by dialing toll-free +1 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and entering access code 722201. A webcast of the call may be acces

    3/24/26 9:05:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    $BGXX
    $BIDU
    $BSFC
    $CEMI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Blue Star Foods Corp.

    SC 13G/A - Blue Star Foods Corp. (0001730773) (Subject)

    11/14/24 7:34:10 PM ET
    $BSFC

    Amendment: SEC Form SC 13G/A filed by Versus Systems Inc.

    SC 13G/A - Versus Systems Inc. (0001701963) (Subject)

    11/14/24 7:30:32 PM ET
    $VS
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Edible Garden AG Incorporated

    SC 13G/A - Edible Garden AG Inc (0001809750) (Subject)

    11/14/24 7:24:20 PM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    $BGXX
    $BIDU
    $BSFC
    $CEMI
    Leadership Updates

    Live Leadership Updates

    View All

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

    Continued clinical execution across TRACTr programs JANX007 and JANX008 JANX007 enrolling in Phase 1b Taxane-naïve patient population in metastatic castration-resistant prostate cancer (mCRPC) JANX008 enrolling expansion cohorts in defined tumor settings Initiated Phase 1 study of JANX011 in healthy volunteers Entered collaboration and exclusive worldwide license agreement with Bristol Myers Squibb to develop a novel tumor-activated therapeutic for solid tumors Appointment of William Go, M.D., Ph.D., as Chief Medical Officer Strong year-end cash position supporting continued pipeline execution Janux Therapeutics, Inc. (NASDAQ:JANX) (Janux), a clinical-stage biopharma

    2/26/26 4:01:00 PM ET
    $JANX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sharplink Announces Record 46% Institutional Ownership, Brand Refresh and Expansion of Leadership Team

    MIAMI, FL, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Sharplink, Inc. (NASDAQ:SBET) ("Sharplink" or the "Company"), one of the world's largest corporate holders of Ether ("ETH") and prominent industry advocate of Ethereum adoption, today announced record level institutional ownership of its common stock. According to the latest available Form 13F filings, institutional ownership of Sharplink's common stock has grown to 46% as of December 31, 2025. The Company's institutional investor base is now one of the largest among all Ethereum-focused digital asset treasury ("DAT") companies. Joseph Chalom, CEO of Sharplink, stated, "This record level of institutional ownership confirms that sophisticated i

    2/19/26 8:00:00 AM ET
    $SBET
    Computer Software: Prepackaged Software
    Technology

    $BGXX
    $BIDU
    $BSFC
    $CEMI
    Financials

    Live finance-specific insights

    View All

    Edible Garden Schedules Fourth Quarter and Full Year Ended December 31, 2025, Financial Results and Business Update Conference Call

    BELVIDERE, NJ, March 24, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leader in controlled environment agriculture (CEA), locally grown, organic, better-for-you, sustainable produce and products, announced today that it will host a conference call on Tuesday March 31, 2026, at 4:30 PM Eastern Time to discuss financial results for the quarter and year ended December 31, 2025, and provide a business update. The conference call will be available via telephone by dialing toll-free +1 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and entering access code 722201. A webcast of the call may be acces

    3/24/26 9:05:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    The Metals Company Announces Fourth Quarter and Full Year 2025 Corporate Update Conference Call for Friday, March 27, 2026

    NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (NASDAQ:TMC) ("TMC" or the "Company"), a leading developer of the world's largest estimated undeveloped resource of critical metals essential to energy, defense, manufacturing and infrastructure, today announced that it will host a conference call on Friday, March 27, 2026, to provide an update on fourth quarter and full year 2025 financial results and recent corporate developments.  Fourth Quarter and Full Year 2025 Conference Call Details  Date:Friday, March 27, 2026  Time:08:00 a.m. ET  Audio-only Dial-in:Register Here  Virtual webcast with slides:Register Here   The virtual webcast will be available for replay in

    3/20/26 8:00:00 AM ET
    $TMC
    Metal Mining
    Basic Materials

    Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update

    Dosed multiple Rett syndrome patients in REVEAL pivotal trial of TSHA-102, with enrollment advancing across multiple sites; on track to complete dosing in Q2 2026 Received FDA clearance to initiate ASPIRE trial in three patients aged 2 to <4 years with inclusion of ≥3 months of safety data in planned BLA submission to support potential for broad label; on track to complete dosing in Q2 2026 Maintained favorable tolerability profile with no treatment-related SAEs or DLTs in REVEAL Phase 1/2 and REVEAL pivotal trials as of March 2026 data cutoff; longer-term safety and efficacy data from Part A of REVEAL Phase 1/2 trials expected in Q2 2026 Reached written alignment with FDA on proposed PPQ

    3/19/26 8:00:00 AM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care